Blood pressure in the very low birth weight neonate

Early Human Development

Volumn 62, Issue 2, 2001, Pages 97-130

  Engle, William D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Neonate; Very low birth weight

Indexed keywords

ADRENALIN; ARGIPRESSIN; CORTICOSTEROID; DEXAMETHASONE; DOBUTAMINE; DOPAMINE; HYDROCORTISONE; HYPERTENSIVE AGENT; METHYLENE BLUE;

BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; HEART OUTPUT; HUMAN; HYPOTENSION; NEWBORN; OUTCOMES RESEARCH; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK; VERY LOW BIRTH WEIGHT;

ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; GESTATIONAL AGE; HUMANS; HYPOTENSION; INFANT CARE; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; REFERENCE VALUES;

EID: 0035080137     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(01)00124-4     Document Type: Review

References (233)

1. Functional development of adrenergic uptake mechanisms in the human fetal heart
2. Cardiovascular function during normal fetal and neonatal development and with hypoxic stress
3. Smooth muscle myosin heavy chain isoforms are developmentally regulated in male fetal and neonatal sheep
4. Differential development of umbilical and systemic arteries: II. Contractile proteins
5. Treatment of congestive heart failure by altering loading conditions of the heart
6. Developmental pharmacology of adrenergic agents
7. Neural regulation of cardiovascular function in the perinatal period
8. Autonomic and central neuroregulation of fetal cardiovascular function
9. Autonomic control of cardiovascular functions during neonatal development and in adult sheep
10. Development of autonomic control of fetal circulation
11. Role of sympathetic activity in the generation of heart rate and arterial pressure variability in fetal sheep
12. Neural regulation of blood pressure during fetal and newborn life
13. Alpha-adrenoceptors in the developing kidney
14. Changes in ovine renal sympathetic nerve activity and baroreflex function at birth
15. Sympathoadrenal mechanisms during development
16. Effect of increased intracranial pressure on blood pressure, heart rate, respiration and catecholamine levels in neonatal and adult rabbits
17. Regulation of renal sympathetic nerve activity at birth
18. Mechanisms of resetting of arterial baroreceptors: an overview
19. Development of baroreflex control of heart rate in swine
20. Ontogeny of baroreflex control of renal sympathetic nerve activity and heart rate
21. Baroreceptors in preterm infants; their relationship to maturity and disease
22. Assessment of spontaneous baroreflex sensitivity in neonates
23. Assessment of baroreflex control of heart rate variability in preterm infants
24. The adrenal glands
25. Role of renin-angiotensin system in response to hemorrhage in fetal sheep
26. Functional development of the kidney in utero
27. Renin-angiotensin and autonomic mechanisms in cardiovascular homeostasis during haemorrhage in fetal and neonatal sheep
28. Ontogeny of vascular angiotensin II receptor subtype expression in ovine development
29. Fetal effects of maternally administered clonidine and angiotensin-converting enzyme inhibitors
30. Neonatal anuria with maternal angiotensin-converting enzyme inhibition
31. Angiotensin-converting enzyme inhibitor fetopathy
32. Blood pressure and angiotensin II in the newborn
33. Development of the renin-angiotensin system
34. Renal response of fetal lamb to complete occlusion of umbilical cord
35. Possible mechanisms of high blood levels of vasopressin during the neonatal period
36. Hemodynamic responses of the sheep fetus to vasopressin infusion
37. An apparent stress-induced release of arginine vasopressin by human neonates
38. Vasopressin: the missing agent in neonatal necrotizing enterocolitis-a hypothesis
39. Vasopressin and pneumothorax in the neonate
40. Mechanism of arginine vasopressin release in the sheep fetus
41. Vasopressin is important for restoring cardiovascular homeostasis in fetal lambs subjected to hemorrhage
42. Cardiovascular effects and clearance of arginine vasopressin in the fetal lamb
43. Factors in the release of vasopressin by the hypoxic fetus
44. Excretion of vasopressin in the hypoxic lamb: comparison between fetus and newborn
45. Urinary arginine vasopressin: pattern of excretion in the neonatal period
46. Cerebrospinal fluid and plasma vasopressin in the fetal lamb: basal concentration and the effect of hypoxia
47. Shock in the pediatric patient: Part I
48. Postnatal changes in the circulation and responses to volume loading in sheep
49. Effects of volume expansion on cardiac output in the preterm infant
50. Nonrenal factors influencing renal function during the perinatal period
51. Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease
52. Randomised controlled trial of plasma protein fraction versus dopamine in hypotensive very low birthweight infants
53. Cardiovascular, renal, and endocrine actions of dopamine in neonates and children
54. Left ventricle output and mean arterial blood pressure in preterm infants during the 21st day of life
55. Systolic blood pressure and blood volume in preterm infants
56. Relation between arterial blood pressure and blood volume and effect of infused albumin in sick preterm infants
57. Echocardiographic assessment of cardiac function in shocked very low birthweight infants
58. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation
59. Response to dobutamine and dopamine in the hypotensive very preterm infant
60. Assessment of non-invasive techniques for measuring blood pressure in preterm infants of birthweight less than or equal to 750 grams
61. Blood pressure measurements in the newborn
62. Blood pressure monitoring in neonates: comparison of umbilical and peripheral artery catheter measurements
63. Blood pressure monitoring in the newborn
64. Noninvasive automatic determination of mean arterial pressure
65. Feasibility of using finger arterial pressure in neonates
66. An automated oscillometric technique for estimating mean arterial pressure in critically ill newborns
67. Oscillometric and intra-arterial blood pressure measurements in the neonate: a comparison of methods
68. Noninvasive determination of systolic, diastolic and end-systolic blood pressure in neonates, infants and young children: comparison with central aortic pressure measurements
69. Accuracy of blood pressure measurement by the dinamap monitor in infants and children
70. Arterial blood pressure in the very low birthweight neonate
71. Dinamap fails to detect hypotension in very low birthweight infants
72. Profiles of mean arterial blood pressure (MAP) for infants weighing 501-1500 grams
73. Prediction of arterial blood pressure in the premature neonate using the oscillometric method
74. Photocell oscillometer for measuring systolic pressure in newborn
75. Blood pressure in normal full-term and premature infants
76. The systemic systolic blood pressure of newborns with low weight
77. Blood pressure norms in low-birth-weight infants: birth through 4 weeks
78. Blood pressure measurements in very low birth weight infants over the first week of life
79. Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants
80. Blood pressure patterns in the first three days of life
81. Blood pressure values in 500- to 750-gram birthweight infants in the first week of life
82. Blood pressure increases, birth weight-dependent stability boundary, and intraventricular hemorrhage
83. Blood pressure, heart rate, and skin temperature in preterm infants: associations with periventricular haemorrhage
84. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study
85. The influence of some perinatal variables on neonatal blood pressure
86. Rate of change of blood pressure in premature and full term infants from birth to 4 months
87. Fetal influences on neonatal blood pressure
88. Blood pressure standards for very low birthweight infants during the first day of life
89. Evidence for an association between birth weight and blood pressure
90. Determinants of blood pressure in very low birth weight neonates: lack of effect of antenatal steroids
91. Observations on blood pressure in newborn infants
92. Aortic blood pressure in normal newborn infants during the first 122 hours of life
93. Aortic blood pressure during the first 12 hours of life in infants with birth weight 610 to 4,220 grams
94. A computerized system for continuous physiologic data collection and analysis: initial report on mean arterial blood pressure in very low-birth-weight infants
95. Cyclical variation of blood pressure and heart rate inneonates
96. Moderate, rapidly induced hypertension as a cause of intraventricular hemorrhage in the newborn beagle model
97. Neonatal blood pressure levels of preterm infants who did and did not develop chronic lung disease
98. Blood pressure ranges in premature infants: I. The first hours of life
99. Blood pressure ranges in premature infants: II. The first week of life
100. Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome
101. Diuresis and respiratory distress syndrome: physiologic mechanisms and therapeutic implications
102. Renal prostaglandins: relationship to the development of blood pressure and concentrating capacity in pre-term and full term healthy infants
103. 2 metabolites in preterm and full-term infants in relation to plasma renin activity and blood pressure
104. Shock and hypotension
105. Prevention, recognition, and treatment of perinatal asphyxia
106. Sympathoadrenal activity and peripheral blood flow after birth, comparison in infants delivered vaginally and by cesarean section
107. Hemodynamic adaptations at birth and neonates delivered vaginally and by cesarean section
108. Vasopressin, ACTH and neonatal haemodynamics
109. Neonatal blood pressure in relation to maturity, mode of delivery, and condition at birth
110. Placental transfusion-advantage and disadvantage
111. Use of albumin in neonatal resuscitation
112. Immediate care of the newborn infant
113. Blood volume in the asphyxiated term neonate
114. Placenta to lamb fetus transfusion in utero during acute hypoxia
115. The effect of intra-partum and intra-uterine asphyxia on placental transfusion in premature and full-term infants
116. Fetal adaptive responses to asphyxia
117. Tight nuchal cord and neonatal hypovolaemic shock
118. The cardiovascular effects of dopamine in the severely asphyxiated neonate
119. Cardiac output in newborn infants with transient myocardial dysfunction
120. Cardiovascular effects of patent ductus arteriosus in preterm lambs with respiratory distress
121. Association of low systolic and diastolic blood pressure with significant patent ductus arteriosus in the very low birth weight infant
122. Effect of patency of the ductus arteriosus on blood pressure in very preterm infants
123. Incidence and risk factors for symptomatic patent ductus arteriosus among inborn very-low-birth-weight infants
124. Symptomatic patent ductus arteriosus in very low-birth-weight infants: 1987-1989
125. Effect of patent ductus arteriosus on left ventricular output in premature infants
126. Pathophysiology of apnea of prematurity
127. Changes in heart rate, blood pressure, and pulse pressure during apnoeic attacks in newborn babies
128. Episodes of apnea and bradycardia in the preterm newborn: impact on cerebral circulation
129. Hemodynamic variables in infants weighing less than 1000 grams
130. Cardiovascular monitoring in infants with respiratory distress syndrome
131. Fluctuating cerebral blood-flow velocity in respiratory-distress syndrome
132. Blood pressure fluctuation and intraventricular hemorrhage in the preterm infant of less than 31 weeks' gestation
133. Cardiopulmonary consequences of positive end-expiratory pressure
134. Effect of continuous positive airway pressure breathing on cardiorespiratory function in infants with respiratory distress syndrome
135. Effect of mechanical ventilation and volume loading on left ventricular performance in premature infants with respiratory distress syndrome
136. Influence of positive end-expiratory pressure on cardiac performance in premature infants: a doppler-echocardiographic study
137. Early determinants of right and left ventricular output in ventilated preterm infants
138. Pulmonary and systemic arterial pressure in hyaline membrane disease
139. Influence of different methods of synchronized mechanical ventilation on ventilation, gas exchange, patient effort, and blood pressure fluctuations in premature neonates
140. Suctioning in the preterm infant: effects on cerebral blood flow velocity, intracranial pressure, and arterial blood pressure
141. Blood pressure responses to care procedures in ventilated preterm infants
142. Cerebral blood flow velocity changes after rapid administration of surfactant
143. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique
144. Cardiorespiratory and stress hormone responses during first dose surfactant administration in neonates with RDS
145. The impact of surfactant replacement therapy on cerebral and systemic circulation and lung function
146. Acute effects on systemic circulation after intratracheal instillation of Curosurf or Survanta in surfactant-depleted newborn piglets
147. Fetal heart rate, arterial pressure, and blood volume responses to cortisol infusion
148. Effects of corticosteroids in preterm sheep on adaptation and sympathoadrenal mechanisms at birth
149. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study
150. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants
151. Hydrocortisone replacement in extremely premature infants with cortisol insufficiency
152. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia
153. Corticosteroid binding globulin, total serum cortisol, and stress in extremely low-birth-weight infants
154. Low serum cortisol in term newborns with refractory hypotension
155. Extraordinary response to dexamethasone therapy for hypotension in a premature newborn: a case report
156. Rapid increase of blood pressure in extremely low birth weight infants after a single dose of dexamethasone
157. Glucocorticoid-responsive hypotension in extremely low birth weight newborns
158. Dexamethasone versus hydrocortisone for hypotension refractory to high dose inotropic agents and incidence of candida infection in extremely low birth weight infants
159. Single-dose dexamethasone treatment of hypotension in preterm infants
160. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring
161. Effect of maternal glucocorticoid exposure on risk of severe intraventricular hemorrhage in surfactant-treated preterm infants
162. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life
163. Effects of prenatal steroids on water and sodium homeostasis in extremely low birth weight neonates
164. Effect of perinatal factors on blood pressure in preterm neonates
165. Antenatal corticosteroids appear to reduce the risk of postnatal germinal matrix hemorrhage in intubated low birth weight newborns
166. Increased blood pressure in neonates and infants whose mothers smoked during pregnancy
167. Blood pressure studies on infants
168. Elevated blood pressure in infants of pre-eclamptic mothers
169. Heart rate and blood pressure in infants of preeclamptic mothers during the first hour of life
170. Decreased cardiac output in infants of mothers who abused cocaine
171. Increased cerebral blood flow velocity in infants of mother who abuse cocaine
172. Circulating catecholamine concentrations in cocaine-exposed neonates: a pilot study
173. Elevated plasma norepinephrine levels in infants of substance-abusing mothers
174. Effect of pancuronium and pethidine on heart rate and blood pressure in ventilated infants
175. Thoracic air leaks
176. Bacterial and fungal infections of the neonate
177. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia
178. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia
179. Low cerebral blood flow: a risk factor in the neonate
180. Blood pressure and cerebral ischemia in very low birth weight infants
181. Low cerebral blood flow in hypotensive perinatal distress
182. Impaired autoregulation of cerebral blood flow in the distressed newborn infant
183. Autoregulation of cerebral blood flow in the newborn beagle puppy
184. Is arterial hypertension crucial for the development of cerebral haemorrhage in premature infants?
185. Mean arterial blood pressure and neonatal cerebral lesions
186. Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage
187. Cerebral blood flow velocity variability after cardiovascular support in premature babies
188. Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants
189. Cerebral blood flow is independent of mean arterial blood pressure in preterm infants undergoing intensive care
190. Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants
191. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years
192. Prevention of intraventricular haemorrhage by fresh frozen plasma
193. Effect of changing plasma volume (PV) on blood pressure (MABP) and prostaglandins (PG) in neonatal puppies
194. The effects of different rates of plasmanate infusions upon brain blood flow after asphyxia and hypotension in newborn piglets
195. Potential adverse effects of volume loading on perfusion of vital organs during closed chest resuscitation
196. The association of rapid volume expansion and intraventricular hemorrhage in the preterm infant
197. Intraventricular hemorrhage following volume expansion after hypovolemic hypotension in the newborn beagle
198. Clinical events in association with timing of intraventricular hemorrhage in preterm infants
199. Cerebral circulation assessed by transcephalic electrical impedance during the first day of life-a potential predictor of outcome
200. Pump up the volume? The routine early use of colloid in very preterm infants
201. Randomised controlled trial of colloid infusions in hypotensive preterm infants
202. Intravenous volume replacement: which fluid and why?
203. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants
204. Use and misuse of albumin infusions in neonatal care
205. The pharmacodynamics of inotropic drugs in premature neonates
206. Neonatal dopamine pharmacodynamics: lessons from the bedside
207. The use of inotroic and afterload-reducing agents in neonates
208. Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease
209. 2 receptors to dopamine-induced increase in glomerular filtration rate
210. Dopamine and natriuresis: mechanism of action and developmental aspects
211. The effect of low-dose dopamine infusion on cardiopulmonary and renal status in premature newborns with respiratory distress syndrome
212. Effects of low-dose dopamine infusion on cardiovascular and renal functions, cerebral blood flow, and plasma catecholamine levels in sick preterm neonates
213. Regional hemodynamic effects of dopamine in the sick preterm neonate
214. The effects of dopamine infusion on regional blood flow in newborn lambs
215. Cardiopulmonary response to dopamine in chronically catheterized neonatal lambs
216. 1, agonist, fenoldopam, used alone or in combination with dopamine and dobutamine
217. Dobutamine: a new synthetic cardioactive sympathetic amine
218. Randomized trial comparing dopamine and dobutamine in preterm infants
219. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome
220. Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants
221. Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock
222. Effect of high-dose dopamine on urine output in newborn infants
223. Use of catecholamines in pediatrics
224. Shock in the pediatric patient: Part II. Therapy
225. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants
226. A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants
227. Effect of methylene blue on refractory neonatal hypotension
228. Methylene blue: NO panacea